Department of Surgery, University of California, San Francisco, CA, USA.
Am J Transplant. 2012 Feb;12(2):409-19. doi: 10.1111/j.1600-6143.2011.03895.x. Epub 2011 Dec 30.
The presence of maternal cells in offspring may promote tolerance to noninherited maternal antigens (NIMAs). Children with biliary atresia (BA) have increased maternal cells in their livers, which may impact tolerance. We hypothesized that patients with BA would have improved outcomes when receiving a maternal liver. We reviewed all pediatric liver transplants recorded in the SRTR database from 1996 to 2010 and compared BA and non-BA recipients of maternal livers with recipients of paternal livers for the incidences of graft failure and retransplantation. Rejection episodes after parental liver transplantation were examined for patients transplanted at our institution. BA patients receiving a maternal graft had lower rates of graft failure compared to those receiving a paternal graft (3.7% vs. 10.5%, p = 0.02) and, consequently, fewer episodes of retransplantation (2.7% vs. 7.5%, p = 0.04). These differences were not seen among non-BA patients or among BA patients who received female deceased donor grafts. In patients transplanted at our institution, paternal liver transplantation was associated with an increased incidence of refractory rejection compared to maternal liver transplantation only in BA. Our data support the concept that maternal cells in BA recipients promote tolerance to NIMAs and may be important in counseling BA patients who require liver transplantation.
母源性细胞在后代中的存在可能促进对非遗传母性抗原 (NIMA) 的耐受。患有胆道闭锁 (BA) 的儿童的肝脏中存在更多的母源性细胞,这可能会影响耐受。我们假设 BA 患者在接受母亲肝脏时会有更好的结果。我们回顾了 1996 年至 2010 年 SRTR 数据库中记录的所有儿科肝移植,并比较了接受母亲肝脏和父亲肝脏的 BA 和非 BA 受体与接受父亲肝脏受体的患者在移植物失功和再次移植的发生率。对在我们机构接受父母肝移植的患者进行了移植后排斥反应发作的检查。与接受父亲供体移植物的患者相比,接受母亲供体移植物的 BA 患者的移植物失功率较低 (3.7% vs. 10.5%,p = 0.02),因此再次移植的次数也较少 (2.7% vs. 7.5%,p = 0.04)。这些差异在非 BA 患者或接受女性已故供体移植物的 BA 患者中没有出现。在我们机构接受移植的患者中,与母亲供体肝移植相比,只有在 BA 患者中,父亲供体肝移植与难治性排斥的发生率增加相关。我们的数据支持这样的概念,即 BA 受者中的母源性细胞促进对 NIMA 的耐受,并且在需要肝移植的 BA 患者的咨询中可能很重要。